Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vilin Bio Med Ltd

NSE: VILINBIO · Pharmaceuticals & Biotechnology · 5 announcements

Share price
₹51.50
Market cap
₹78.54 Cr
Revenue (annual)
₹42.26 Cr
Net profit (annual)
₹1.93 Cr
P/E (TTM)
40.7×Sector 50.4×
Promoter holding
56.65%-2.92% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:14 IST NSE
Acquisition

Vilin Bio Med Acquisition

Vilin Bio Med disclosed NCLT Hyderabad allowed its amalgamation with Chemgenix Laboratories Pvt Ltd. The order directs convening shareholder and creditor meetings for both companies.